publish
elsevi
scienc
bv
pii
base
tenet
common
mucos
immun
system
antigen
stimul
one
mucos
site
result
distribut
antigenspecif
iga
precursor
cell
distant
mucos
site
howev
recent
studi
suggest
function
compartment
limit
reciproc
may
exist
within
compon
common
mucos
immun
system
although
oral
immun
often
effect
induc
immun
respiratori
pathogen
convers
respiratori
immun
prevent
enter
diseas
may
effect
address
question
studi
interact
bronchusassoci
balt
gutassoci
galt
lymphoid
tissu
relat
protect
immun
use
model
two
antigen
relat
porcin
coronavirus
replic
primarili
intestin
transmiss
gastroenter
viru
tgev
respiratori
tract
porcin
respiratori
coronaviru
prcv
tissu
distribut
magnitud
antibodi
secret
cell
asc
respons
measur
elispot
cellmedi
immun
respons
measur
lymphoprolif
assay
lpa
coincid
viral
tissu
tropism
immun
via
galt
gut
infect
tgev
elicit
high
number
iga
asc
high
lpa
respons
galt
gut
lamina
propria
lp
mesenter
lymph
node
mln
lower
respons
balt
bronchial
lymph
node
bln
induc
complet
protect
enter
tgev
challeng
contrast
immun
via
balt
respiratori
infect
prcv
elicit
system
type
respons
high
number
igg
asc
bln
asc
low
lpa
respons
gut
lp
mln
induc
partial
protect
enter
tgev
challeng
thu
administr
vaccin
intranas
may
optim
effect
induc
intestin
immun
contrast
report
efficaci
oral
vaccin
induc
respiratori
immun
uniqu
mucos
immun
system
independ
system
immun
system
evolv
protect
mucos
surfac
pathogen
exclud
environment
antigen
foreign
protein
therebi
prevent
evok
systemictyp
inflammatori
immun
respons
review
newbi
mestecki
brandtzaeg
mcghee
et
al
husband
mucos
immun
system
character
preponder
secretori
iga
antibodi
select
secret
onto
mucos
surfac
activ
transport
mechan
polyimmunoglobulin
receptor
pigr
siga
antibodi
play
major
role
preserv
mucos
integr
downregul
system
type
immun
respons
prevent
invas
pathogen
mucosa
block
attach
invas
neutral
lumen
intracellularli
immun
exclus
function
contrast
system
induc
igg
antibodi
mediat
inflammatori
reaction
lead
kill
elimin
pathogen
therebi
maintain
steril
system
organ
tissu
although
earlier
studi
siga
envis
act
mainli
lumin
mucos
surfac
recent
data
suggest
dimer
iga
may
bind
antigen
basolater
side
intestin
epitheli
cell
kaetzel
et
al
immun
complex
would
transport
across
epitheli
cell
via
pigr
secret
back
intestin
lumen
therebi
elimin
foreign
antigen
penetr
epithelium
least
two
recent
report
suggest
siga
may
function
intracellularli
host
defens
inhibit
viral
replic
assembl
vitro
armstrong
dimmock
marzanec
et
al
vivo
bum
et
al
find
impli
slga
promot
recoveri
viral
infect
well
initi
protect
anoth
uniqu
featur
mucos
immun
system
compar
system
immun
system
induct
antigenspecif
b
cell
iga
induct
organ
lymphoid
tissu
galt
balt
etc
distribut
remot
mucos
effector
site
ie
lamina
propria
region
intestin
bronchi
genitourinari
tract
secretori
gland
cellular
distribut
pathway
link
distant
mucos
site
refer
common
mucos
immun
system
mestecki
although
origin
propos
activ
igacommit
b
cell
thelper
th
cell
traffic
equal
well
secretori
tissu
independ
origin
mestecki
becom
recogn
compartment
region
occur
within
common
mucos
immun
system
exampl
iga
precursor
cell
deriv
galt
readili
repopul
gut
lamina
propria
distant
mucos
site
cebra
et
al
brandtzaeg
also
distant
migrat
cell
balt
limit
galt
sminia
et
al
balt
exposur
often
lead
dissemin
noniga
commit
secondari
b
cell
cebra
et
al
similarli
immun
via
lower
intestin
tract
may
lead
greater
mucos
immun
respons
genit
tract
immun
via
upper
intestin
tract
kagnoff
observ
import
implic
design
effect
mucos
vaccin
demonstr
compar
studi
mucos
immun
induc
infect
pig
enter
versu
respiratori
coronavirus
brim
et
al
van
cott
et
al
latter
result
discuss
greater
detail
subsequ
section
pathogen
enter
infect
host
way
mucos
surfac
make
local
mucos
immun
respons
paramount
import
host
defens
number
investig
varieti
speci
provid
evid
induct
igaprecursor
cell
galt
oral
administ
antigen
lead
dissemin
effector
cell
molecul
intestin
remot
mucos
tissu
secret
review
mestecki
mcghee
et
al
antigen
taken
via
cell
process
via
galt
peyer
patch
pp
aggreg
lymphoid
tissu
lamina
propria
induc
activ
b
cell
migrat
pp
mln
via
thorac
duct
system
circul
subsequ
repopul
distant
mucos
tissu
matur
b
cell
iga
plasma
cell
occur
within
mucos
effector
site
respons
antigen
cell
cytokin
lehman
coffman
thu
key
studi
rabbit
confirm
pp
enrich
sourc
iga
precursor
cell
repopul
lamina
propria
intestin
craig
cebra
although
gener
concept
relat
mucos
immun
elabor
establish
inform
effect
practic
procedur
induc
protect
immun
mucos
surfac
lack
particular
oral
immun
nonrepl
solubl
antigen
induc
poor
siga
respons
short
durat
newbi
led
oral
toler
andr
et
al
review
mowat
current
hypothes
explain
result
oral
toler
suggest
antigen
solubl
nonrepl
antigen
present
process
via
normal
villou
epitheli
cell
mainli
suppressor
cell
induc
lead
suppress
immun
respons
bland
warren
mayer
shlien
number
strategi
propos
overcom
inher
downregulatori
mechan
associ
induct
mucos
immun
via
oral
immun
includ
improv
antigen
deliveri
system
use
biodegrad
microspher
protect
antigen
low
ph
target
mucos
induct
site
pp
eldridg
et
al
live
recombin
vector
replic
mucos
site
express
recombin
antigen
interest
also
develop
includ
avirul
strain
sulmonezlu
curtiss
et
al
escherichiu
coli
hale
well
indigen
strain
lactubacih
gerrits
et
al
variou
attenu
virus
also
studi
includ
recombin
adenovirus
morin
et
al
vaccinia
viru
rupprecht
et
al
ramsay
et
al
coexpress
cytokin
gene
influenza
viru
ha
gene
latter
vector
led
enhanc
iga
antibodi
respons
influenza
viru
ha
respiratori
tract
ramsay
et
al
number
adjuv
also
shown
effect
enhanc
mucos
immun
respons
includ
cholera
toxin
tamura
et
al
israel
et
al
liposom
husband
avridin
anderson
et
al
muranyl
dipeptid
mcghee
et
al
husband
date
success
strategi
induct
protect
immun
via
oral
immun
mainli
reli
use
live
replic
vaccin
aforement
special
adjuv
deliveri
system
number
studi
variou
speci
demonstr
efficaci
oral
immun
induct
protect
immun
remot
mucos
site
exampl
oral
immun
induc
protect
respiratori
tract
includ
follow
protect
bacteri
infect
oral
deliveri
cultur
supernat
pasteurella
haemolytica
poli
hydrogel
cattl
result
reduc
pneumon
lesion
upon
challeng
bowersock
et
al
oral
inocul
human
hemophilu
injluenza
result
decreas
colon
incid
respiratori
infect
organ
clanci
et
al
case
viral
infect
oral
administr
adenoviru
vaccin
use
prevent
human
respiratori
adenoviru
infect
dud
et
al
schwartz
protect
distant
mucos
surfac
also
achiev
oral
immun
inocul
rat
streptococcu
mutan
prevent
dental
carri
michalek
et
al
exposur
swine
enteropathogen
transmiss
gastroenter
viru
tgev
induc
passiv
protect
piglet
mediat
siga
antibodi
milk
bohl
et
al
saif
et
al
although
immun
via
galt
effect
gener
protect
immun
respons
certain
pathogen
distant
mucos
site
less
success
achiev
develop
oral
vaccin
activ
protect
target
intestin
epitheli
cell
infect
enteropathogen
virus
use
live
attenu
polioviru
often
cite
model
effect
oral
vaccin
mechan
viral
pathogenesi
henc
protect
immun
differ
need
prevent
viral
diarrhea
polioviru
undergo
primari
replic
pp
intestin
lymphoid
cell
epitheli
cell
target
cell
diseas
induct
neuron
melnick
thu
stimul
circul
antibodi
use
either
live
oral
inactiv
polioviru
vaccin
prevent
system
spread
polioviru
central
nervou
system
paralyt
diseas
enteropathogen
virus
infect
epitheli
cell
mani
induc
lesion
intestin
stimul
local
immun
respons
within
intestin
need
effect
prevent
gastrointestin
diseas
date
howev
commerci
experiment
candid
vaccin
highli
effect
prevent
enter
viral
infect
gastroenter
human
anim
review
kapikian
chanock
saif
jackwood
poor
efficaci
frequent
encount
field
use
live
oral
parenter
administ
vaccin
prevent
coronaviru
rotavirusinduc
diarrhea
swine
cattl
saif
jackwood
likewis
clinic
trial
candid
rotaviru
vaccin
infant
often
fail
variou
aspect
safeti
immunogen
efficaci
especi
test
develop
countri
kapikian
chanock
studi
activ
passiv
immun
respons
protect
immun
induc
use
liveattenu
oral
tgev
vaccin
swine
reveal
high
degre
attenu
lead
reduc
viral
replic
intestin
sow
saif
jackwood
saif
wesley
use
low
moder
oral
dose
live
attenu
tgev
vaccin
pfu
ml
piglet
van
cott
et
al
brim
et
al
saif
et
al
major
determin
failur
induc
siga
antibodi
sow
milk
iga
asc
piglet
intestin
respect
correspond
lack
efficaci
similarli
studi
natur
rotaviru
infect
children
higher
fecal
iga
antibodi
titer
rotavinr
associ
protect
infect
ill
matson
et
al
anim
studi
rotavirusinduc
diseas
reveal
similar
find
induct
intestin
iga
antibodi
respons
asc
high
local
lymphoprolif
respons
posit
associ
protect
rotaviru
diarrhea
feng
et
al
saif
et
al
result
suggest
research
need
optim
enter
vaccin
induc
local
mucos
immun
respons
close
mimic
one
elicit
exposur
virul
organ
compartment
within
common
mucos
immun
system
studi
tgevprcv
coronaviru
model
swine
two
antigen
relat
porcin
coronavirus
distinct
tissu
tropism
enter
tgev
respiratori
prcv
provid
ideal
model
studi
interact
balt
galt
induct
mucos
immun
protect
enteropathogen
tgev
strain
brim
et
al
saif
et
al
van
cott
et
al
exposur
pig
tgev
prcv
result
distinct
diseas
pattern
relat
differ
tissu
tropism
two
virus
saif
wesley
saif
et
al
tgev
replic
small
intestin
villou
epitheli
cell
induc
villou
atrophi
malabsorpt
diarrhea
lead
nearli
mortal
seroneg
neonat
pig
prcv
strain
replic
respiratori
tract
littl
replic
intestin
gener
caus
subclin
infect
mild
respiratori
diseas
tgev
infect
remain
lead
caus
piglet
diarrhea
mortal
swine
herd
commerci
vaccin
even
live
attenu
oral
vaccin
limit
efficaci
field
saif
wesley
previou
studi
prcv
induc
partial
protect
experiment
challeng
tgev
van
nieuwstadt
et
al
cox
et
al
mechan
involv
elucid
therefor
sought
explor
feasibl
use
prcv
candid
vaccin
prevent
tgev
use
enter
diseas
model
delin
interact
balt
galt
induct
protect
mucos
immun
three
group
ldayold
tgev
seroneg
pig
oronas
inocul
virul
tgev
prcv
mockinfect
cellcultur
fluid
respect
challeng
day
later
virul
tgev
brim
et
al
saif
et
al
van
cott
et
al
immun
respons
intestin
gut
lamina
propria
mesenter
lymph
node
mln
respiratori
bronchial
lymph
node
bln
system
spleen
lymphoid
tissu
assess
challeng
variou
postchalleng
day
enumer
iga
igg
tgevspecif
antibodi
secret
cell
asc
elispot
lymphoprolif
assay
lpa
use
inactiv
tgev
antigen
major
find
follow
pig
inocul
tgev
develop
diarrhea
shed
tgev
fece
recov
presenc
high
number
igaasc
gut
lamina
propria
high
lpa
respons
mln
challeng
correl
complet
protect
tgev
challeng
signific
increas
observ
number
asc
lpa
respons
gut
lp
mln
respect
neutral
antibodi
titer
serum
tgev
challeng
reflect
lack
viral
replic
associ
complet
protect
contrast
pig
inocul
prcv
clinic
diseas
shed
viru
nasal
secret
fece
challeng
prcvexpos
pig
mainli
igg
asc
high
lpa
respons
bln
low
asc
number
lpa
respons
intestin
gut
lp
mln
respect
partial
protect
diarrhea
develop
diarrhea
fecal
tgev
shed
observ
tgev
challeng
number
iggasc
lesser
extent
igaasc
increas
rapidli
bln
prcvexpos
pig
suggest
virusspecif
iggasc
precursor
deriv
balt
prcvexpos
pig
may
migrat
intestin
respons
tgev
challeng
contribut
partial
protect
observ
interestingli
found
higher
number
igaasc
balt
tgevexpos
pig
prcvexpos
pig
tgev
challeng
consist
previou
observ
indic
traffick
iga
precursor
cell
galt
balt
mestecki
mcghee
et
al
husband
thu
tgev
replic
gut
may
increas
number
tgevspecif
igaasc
balt
via
traffick
galtderiv
iga
cell
balt
one
might
specul
tgev
infect
vaccin
induc
immun
via
galt
secondarili
balt
may
prevent
prcv
infect
whether
frequent
use
live
attenu
tgev
vaccin
us
compar
europ
impact
limit
spread
prcv
infect
us
unknown
present
prcv
infect
appear
much
widespread
among
swine
europ
us
thu
major
conclus
function
compartment
exist
balt
galt
respons
immun
via
balt
prcv
infect
induc
system
type
respons
iggasc
low
asc
lpa
respons
gut
provid
incomplet
protect
enter
pathogen
immun
via
galt
tgev
infect
induc
high
number
igaasc
high
lpa
respons
gut
provid
complet
protect
enter
diseas
studi
induct
immun
regul
respons
tgev
prcv
affect
distribut
pattern
asc
tlymphocyt
provid
import
insight
optim
oral
vaccin
regimen
elicit
protect
mucos
immun
respons
enter
pathogen
